878113C

C16-20:4 PC

Avanti Research^™ - A Croda Brand 878113C

• Synonym(e): 1-O-hexadecyl-2-arachidonoyl-sn-glycero-3-phosphocholine
• Empirische Formel (Hill-System): C₄₄H₈₂NO₇P
• CAS-Nummer: 86288-11-1
• Molekulargewicht: 768.10
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: liquid
• Verpackung: pkg of 1 × 1 mL (878113C-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 878113C
• Konzentration: 5 mg/mL (878113C-5mg)
• Lipid-Typ: bioactive lipids; phosphoglycerides
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COCCCCCCCCCCCCCCCC)=O
• InChI: 1S/C44H82NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-44(46)52-43(42-51-53(47,48)50-40-38-45(3,4)5)41-49-39-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h14,16,20,22,24-25,29,31,43H,6-13,15,17-19,21,23,26-28,30,32-42H2,1-5H3/b16-14-,22-20-,25-24-,31-29-/t43-/m1/s1
• InChIKey: DUUSFCFZBREELS-WWBBCYQPSA-N

Beschreibung

Allgemeine Beschreibung

C16-20:4 PC is an analog to platelet-activation factor (PAF).

Verpackung

5 mL Clear Glass Sealed Ampule (878113C-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372
• P-Sätze: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system
• WGK: WGK 3